22 Messerli FH,Weber MA,Brunner HR.Angiotensin Ⅱ receptor inhibition:A new therapeuticprinciple.Arch Intern Med 1996；156：1957
33，Cody RJ,Binkley PF,Haas GJ,et al.Acute myocardial and vascular responses to specificangiotensin Ⅱ antagonism in the spontaneously hypertensive rats.Am J Hypertens 1995；8(5pt Ⅰ)：500～508
44，Bauer IH,Reams GP,Wu Z,et al.Effects of losartan on the renin-angiotensin-aldosteroneaxis in essential hypertension.J Hum Hypertens 1995；9(4)：237～243
55，Grossman E,Peley E,Carroll J,et al.Hemodynamic and humoral effects of the angiotensinⅡ antagonists losartan in essential hypertension.An J Hypertens 1994；7(12)：1041～1004
66，Niederberger M,Aubert JF,Nussberger J,et al.Sympathetic nerve activity in consciousrenal hypertensive treated with an angiotensin converting enzyme inhibitor or angiotensinⅡ antagonist.J Hypertens 1995；13(4)：439～445
88，Goldery MR,Bradstreet TE,Mcwilliams EJ,et al.Biochemical effects of losartan,anonpeptide angiotensin Ⅱ antagonist,on the renin-angiotensin-aldosterone system inhypertensive patients.Hypertension 1995；25(1)：37～46
99，Berecek KH,Robertson JD,Thorstal MH.Central adminstration of a specific angiotensinⅡ receptor antagonist on barorefflex function in spontaneously hypertensive rats.JHypertens 1995；9(4)：365～371
1010，Guan H,Cachofeiro V,Pucci ML,et al.Nitric oxide and the depresssor response toangiotensin blockade in hypertension.Hypertension 1996；27(1)：19～24
